Teladoc: When Valuation Sets a Low Bar
Shareholders of telehealth company Teladoc Health (NYSE: TDOC) have gone from feeling like heroes as the stock grew by leaps and bounds during COVID-19 lockdowns to zeros after the stock has fallen 75% from its nearly $300 high. Large share price swings like this are understandably frustrating for investors.
But looking forward is the name of the game, and that's the best course of action for investors looking at Teladoc Health. The good news is that the stock's brutal sell-off has priced it at a bargain-level valuation that could reward patient investors moving forward, and here's why.
Image source: Getty Images.
Source Fool.com
